John Libbey Eurotext

European Journal of Dermatology


Infantile bullous pemphigoid following vaccination Volume 28, issue 5, September-October 2018


  • Figure 1
1 Laboratory of Molecular and Cell Biology, Istituto Dermopatico dell’Immacolata, IRCCS, Rome, Italy
2 1st Dermatology Division, Istituto Dermopatico dell’Immacolata, IRCCS, Rome, Italy
3 Genetic and Rare Diseases Research Area, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy
a These authors contributed equally

Bullous pemphigoid (BP) is a rare autoimmune blistering disease associated with circulating autoantibodies against the hemidesmosomal proteins, BP180 (BPAG2) and BP230 (BPAG1) [1]. In particular, BP180 autoantibodies are critical for disease induction [1]. BP mostly affects the elderly and manifests with generalized tense blisters and eczematous- or urticarial-like lesions [1], while infantile BP is considered rare and characterized by major acral involvement [2]. BP diagnosis is based on clinical [...]